Paradigm BioCapital
Overview
Paradigm BioCapital is a hedge fund manager and investment adviser that primarily invests in transformative therapeutics and the biotechnology sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
| Acrivon Therapeutics | Apr 2024 | PIPE | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Paradigm BioCapital based?
Paradigm BioCapital is headquartered in New York City, New York, United States.
When was Paradigm BioCapital founded?
Paradigm BioCapital was founded in 2020.
How many portfolio companies does Paradigm BioCapital have?
Paradigm BioCapital has 3 portfolio companies in Caplight's dataset.
What are some companies in Paradigm BioCapital's portfolio?
Portfolio companies visible on Caplight include Obsidian Therapeutics, Acrivon Therapeutics.
What was Paradigm BioCapital's most recent investment shown here?
Paradigm BioCapital's most recent investment in this portfolio sample was in Obsidian Therapeutics in 2026.
What sectors does Paradigm BioCapital focus on?
Paradigm BioCapital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Paradigm BioCapital focus on?
Paradigm BioCapital typically invests at the Mid stage.
What is Paradigm BioCapital's AUM?
Paradigm BioCapital's assets under management are estimated between $3.1B and $3.5B.